Search

Neuromyelitis Optica Spectrum Disorder: Updates on Diagnosis and Treatment Management

Valid: July 7, 2023 through July 6, 2024 Provider Statement This continuing education activity is provided by  Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. Activity Description Neuromyelitis optica spectrum disorder (NMOSD) is a rare, relapsing, autoimmune disease of the central nervous system that is characterized by inflammation …